MESOBLAST LTD
MESODrugs in Pipeline
19
Phase 3 Programs
8
Upcoming Catalysts
1
Next Catalyst
Oct 15, 2026
31wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Rexlemestrocel-L
Degenerative Disc Disease
adult human mesenchymal stem cells
Crohn's Disease
Prochymal®
Graft Versus Host Disease
remestemcel-L
Grade B aGVHD
PROCHYMAL adult human mesenchymal stem cells
Crohn's Disease
Infusion of one MPC expanded cord unit and one unexpanded cord unit
Acute Myelogenous Leukemia
Allogeneic Mesenchymal Precursor Cells (MPCs)
Chronic Heart Failure
Rexlemestrocel-L + HA mixture
Degenerative Disc Disease
Allogeneic Mesenchymal Precursor Cells
Rheumatoid Arthritis
Mesenchymal Precursor Cells (MPC) 12.5 M
Acute Myocardial Infarction
Prochymal
Graft Versus Host Disease
Prochymal™ adult human mesenchymal stem cells
Crohn's Disease
Single Dose MPCs Injection
Degenerative Disc Disease
Lumbar Interbody Fusion with Autograft
Degenerative Disc Disease
Prochymal® - 2 Million cells/kg
Graft Vs Host Disease
MSB-CAR001 Combined With Hyaluronan
Anterior Cruciate Ligament Injury
Prochymal™
Pulmonary Disease, Chronic Obstructive
Mesenchymal Precursor Cells (MPCs)
Diabetic Nephropathy
NeoFuse
Cervical Degenerative Disc Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Rexlemestrocel-L | Phase 3 | Degenerative Disc Disease | - | - |
adult human mesenchymal stem cells | Phase 3 | Crohn's Disease | - | - |
Prochymal® | Phase 3 | Graft Versus Host Disease | - | - |
remestemcel-L | Phase 3 | Grade B aGVHD | - | - |
PROCHYMAL adult human mesenchymal stem cells | Phase 3 | Crohn's Disease | - | - |
Infusion of one MPC expanded cord unit and one unexpanded cord unit | Phase 3 | Acute Myelogenous Leukemia | - | - |
Allogeneic Mesenchymal Precursor Cells (MPCs) | Phase 3 | Chronic Heart Failure | - | - |
Rexlemestrocel-L + HA mixture | Phase 3 | Degenerative Disc Disease | - | - |
Allogeneic Mesenchymal Precursor Cells | Phase 2 | Rheumatoid Arthritis | - | - |
Mesenchymal Precursor Cells (MPC) 12.5 M | Phase 2 | Acute Myocardial Infarction | - | - |
Prochymal | Phase 2 | Graft Versus Host Disease | - | - |
Prochymal™ adult human mesenchymal stem cells | Phase 2 | Crohn's Disease | - | - |
Single Dose MPCs Injection | Phase 2 | Degenerative Disc Disease | - | - |
Lumbar Interbody Fusion with Autograft | Phase 2 | Degenerative Disc Disease | - | - |
Prochymal® - 2 Million cells/kg | Phase 2 | Graft Vs Host Disease | - | - |
MSB-CAR001 Combined With Hyaluronan | Phase 2 | Anterior Cruciate Ligament Injury | - | - |
Prochymal™ | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
Mesenchymal Precursor Cells (MPCs) | Phase 2 | Diabetic Nephropathy | - | - |
NeoFuse | Phase 2 | Cervical Degenerative Disc Disease | - | - |